Yumei Kidney Disease Hospital
Products
Contact Us
  • Contact Person : Mr. Coline Cao
  • Company Name : Yumei Kidney Disease Hospital
  • Tel : 86-010-58411143
  • Fax : 86-010-58411139
  • Address : Beijing,Beijing,No.27,Yingbin North Road,Yan Jiao ETDZ,Beijing,China
  • Country/Region : China
  • Zip : 065210

Children Diabetic Nephropathy Treatment

Children Diabetic Nephropathy Treatment
Product Detailed
Related Categories:Agricultural Product Stock
If you want to know children diabetic nephropathy treatment without dialysis options,Website:http://www.yumei-kidney.com, or you want to consult children diabetic nephropathy treatment price and pricelist, Jingdong Yumei Kidney Disease Hospital is always at your service.Children Diabetic Nephropathy Treatment Diabetic Nephropathy is a progressive kidney disease caused by angiopathy of capillaries in the glomeruli. It is characterized by Nephrotic Syndrome and Diffuse Glomerulosclerosis. It is caused by longstanding Diabetes Mellitus, and is a prime indication for dialysis in many Western countries. However, how to treat Children Diabetic Nephropathy? Commonly, the treatment include:1.Low protein diet: if children with Diabetic Nephropathy can stick to low protein diet, glomerular high perfusion state can be relieved, protein urine can be decreased, and kidney function can be stabilized.2. Control blood sugar: children with Diabetic Nephropathy should strictly control the blood sugar to reduce glomerular high filtration, lower the onset rate of urinary infection and prevent urinary infection which may impair kidney function further. 3. Antihypertension treatment: Hypertension can accelerate Diabetic Nephropathy development and deterioration. If the blood pressure can be controlled well at the early time, it can reduce urine protein and delay GFR decrease. 4. Antiplatelet and microcirculation improving drugs: Asprin, and Dipyridamole have the effects of stabilizing kidney function and reducing protein urine.


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.